Budapest, Hungary

Pal Ivan

This inventor holds 1 USPTO granted patent. Top assignee: Egyt Gyogyszervegyeszeti Gyar. Active years: 1985.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pal Ivan

Introduction

Pal Ivan is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. His work has the potential to impact the treatment of viral infections, showcasing the importance of innovation in medicine.

Latest Patents

Pal Ivan holds a patent for a process related to the preparation of 5-(2-bromovinyl)-uridine. This invention pertains to (E)-5-(2-bromovinyl)-uridine and its derivatives, which exhibit significant potency against Herpes simplex virus species while maintaining remarkably low acute toxicity. The process involves brominating 2',3',5'-tri-O-acyl-5-ethyl-uridine and dehydrohalogenating the resulting dibromo compound, with optional deacylation to yield the final products.

Career Highlights

Pal Ivan is associated with Egyt Gyogyszervegyeszeti Gyar, where he has been instrumental in advancing pharmaceutical research. His innovative approach to drug development has garnered attention in the scientific community. With a focus on antiviral agents, he continues to explore new methodologies to enhance therapeutic efficacy.

Collaborations

Pal Ivan has worked alongside talented colleagues, including Anna Szabolcs Nee Borbas and Janos Sagi. Their collaborative efforts have contributed to the success of various projects within the company, fostering a dynamic research environment.

Conclusion

Pal Ivan's contributions to the field of pharmaceuticals highlight the critical role of inventors in advancing medical science. His innovative work in developing antiviral compounds demonstrates the potential for significant impact on public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…